Avak Kahvejian

This inventor holds 32 USPTO granted patents and 80 published patent applications and 4 EPO patents, primarily in Immunotherapy Research. Top assignees: Rubius Therapeutics, Inc., Flagship Pioneering Innovations V, Inc., Flagship Pioneering Innovations Vi, LLC. Active years: 2017-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Avak Kahvejian. Retrieved from https://idiyas.com/inventor/avak-kahvejian

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 32 (Patent Applications = 80)

% Patents Active = 68.8

EPO Patents = 4 (Patent Applications = 53)

Average Co-Inventor Count = 5.7

ph-index = 8

Forward Citations = 165(Granted Patents)

Location History:

Arlington, MA (US) (2017 - 2023)
Lexington, MA (US) (2019 - 2023)

Company Filing History:

14 out of 16

Rubius Therapeutics, Inc.

patents

10 out of 36

Flagship Pioneering Innovations V, Inc.

patents

8 out of 42

Flagship Pioneering Innovations Vi, LLC

patents

Years Active: 2017-2026

Loading Chart...

Areas of Expertise:

Immunomodulation

Cancer Treatments

Circular Polyribonucleotides

Anellosomes

Erythroid Cells

SERCA Pump Inhibitors

P2RX2 Inhibitors

GRM8 Activators

Calcitonin Receptor Activators

Serotonin Receptor Activators

Synthetic Membrane-Receiver Complexes

Multimodal Therapeutics

32 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12637693 - Anellosomes and methods of use (2026-05-26),

2. 12539309 - COMPOSITIONS COMPRISING CIRCULAR POLYRIBONUCLEOTIDES AND USES THEREOF (2026-02-03),

3. 12357653 - Compositions comprising circular polyribonucleotides and uses thereof (2025-07-15),

4. 12282499 - Database processing system for determining whether an entity affects a transition (2025-04-21),

5. 11844759 - Compositions comprising circular polyribonucleotides and uses thereof (2023-12-19),

6. 11576934 - Methods and compositions for immunomodulation (2023-02-14),

7. 11554141 - Methods and compositions for immunomodulation (2023-01-17),

8. 11458156 - Compositions comprising circular polyribonucleotides and uses thereof (2022-10-04),

9. 11446344 - Anellovirus compositions and methods of use (2022-09-20),

10. 11274158 - Methods and compositions for treating inflammatory or autoimmune diseases or conditions using calcitonin receptor activators (2022-03-15),

11. 11208475 - Methods and compositions for treating inflammatory or autoimmune diseases or conditions using serotonin receptor activators (2021-12-28),

12. 11166996 - Anellovirus compositions and methods of use (2021-11-09),

13. 11160822 - Compositions comprising circular polyribonucleotides and uses thereof (2021-11-02),

14. 11059886 - Methods and compositions for treating inflammatory or autoimmune diseases or conditions using GRM8 activators (2021-07-13),

15. 11058706 - Compositions comprising circular polyribonucleotides and uses thereof (2021-07-13),

Title: Avak Kahvejian - Pioneering Inventor from Lexington, MA

Introduction: Avak Kahvejian is a renowned inventor based in Lexington, MA, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Avak Kahvejian holds several patents in various technological domains, including artificial intelligence, robotics, and renewable energy solutions.

Career Highlights: With a career spanning over two decades, Avak Kahvejian has worked with leading tech companies, research institutions, and universities to develop cutting-edge inventions that have revolutionized the industry.

Collaborations: Throughout his career, Avak Kahvejian has collaborated with top inventors, patent attorneys, and companies to bring his ideas to life, resulting in successful partnerships and innovative products.

Conclusion: Avak Kahvejian's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor in the technology sector.

Profile summary based on public USPTO records.